(Q81985539)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800145%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800145%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

4

P M Sandset

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800145%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

H F S Negaard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800145%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

N Iversen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800145%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

I M Bowitz-Lothe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800145%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

B Steinsvik

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800145%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

B Ostenstad

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800145%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

P O Iversen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800145%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

18 September 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800145%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800145%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800145%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800145%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

162-169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18800145%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2008.255

14 January 2020

exact match

0 references

cites work

Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various cl

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Angiogenesis and antiangiogenic therapy in hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Soluble tissue factor has unique angiogenic activities that selectively promote migration and differentiation but not proliferation of endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Angiogenesis and hemostasis in hematological neoplasias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Monocyte/macrophage infiltration in tumors: modulators of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Guidelines on the diagnosis and management of chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Guidelines on the diagnosis and management of multiple myeloma 2005.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Histological quantitation of tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Predicting benefit from anti-angiogenic agents in malignancy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Response to thalidomide in multiple myeloma: impact of angiogenic factors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Role of chemokines in tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

https://api.crossref.org/works/10.1038%2FLEU.2008.255

1 reference

7 January 2021

Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021

Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.255

7 January 2021